{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:32:41Z","timestamp":1788903161844,"version":"build-2803163510"},"reference-count":450,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Cancer research has undergone a transformative change with the advent of high-throughput genomic technologies. Advances in next-generation sequencing accelerated the identification of somatic and germline alterations that drive tumorigenesis enabling the transition from traditional histology-based cancer classification to molecularly informed precision oncology. Large-scale sequencing initiatives and clinical genomic profiling facilitated the development of companion diagnostic assays and targeted therapies. Beyond targeted therapies, genomic innovations have also catalyzed the emergence of novel therapeutic strategies including immunogenomics-driven immunotherapies, RNA-based therapeutics, cancer vaccines and genome editing technologies based on CRISPR-Cas systems. This review summarizes the major technological developments in cancer genomics, including sequencing platforms, transcriptomic profiling, liquid biopsy, and functional genomic screening, and highlights the utility of these innovations in discovery of actionable biomarkers and next-generation therapeutic strategies. Collectively, these advances underscore the central role of genomic technologies in driving the evolution of precision oncology toward more personalized and effective cancer treatment strategies.<\/jats:p>","DOI":"10.3389\/fgene.2026.1828450","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:42:01Z","timestamp":1783298521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic innovations in cancer prevention, diagnosis, prognosis and precision therapeutics"],"prefix":"10.3389","volume":"17","author":[{"given":"Hanumappa","family":"Ananda","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Connecticut School of Medicine","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhu R.","family":"Sahana","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi R.","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrutha N.","family":"Kunnath","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal Academy of Higher Education","place":["Manipal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Prashant","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]},{"name":"Department of Biochemistry, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussuf T.","family":"Kaifi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ellis Fischel Cancer Center, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pura K.","family":"Kiran","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanve N.","family":"Suvilesh","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research","place":["Mysore, Karnataka, India"]},{"name":"Department of Surgery, Ellis Fischel Cancer Center, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood-2013-04-495531","article-title":"Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes","volume":"122","author":"Abate-Daga","year":"2013","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/JS9.0000000000000334","article-title":"Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence","volume":"109","author":"Abbasi","year":"2023","journal-title":"Int. J. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1574359","DOI":"10.3389\/fbinf.2025.1574359","article-title":"Artificial intelligence in variant calling: a review","volume":"5","author":"Abdelwahab","year":"2025","journal-title":"Front. Bioinformatics."},{"key":"B5","volume-title":"Genetics, Epigenetic Mechanism","author":"Al Aboud","year":"2026"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/2159-8290.CD-25-0164","article-title":"From Discovery to Diagnosis: A Perspective for Circulating Tumor Cells in Personalized Oncology","volume":"15","author":"Alix-Panabi\u00e8res","year":"2025","journal-title":"Cancer Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13046-018-0702-x","article-title":"Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations","volume":"37","author":"Allegretti","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1038\/s41598-025-89915-z","article-title":"Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis","volume":"15","author":"Alwashmi","year":"2025","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ijc.70121","article-title":"Harnessing viral footprints in circulating free DNA (cfDNA) for early cancer detection: A focus on liquid-biopsy-based screening","volume":"158","author":"Amponsah","year":"2026","journal-title":"Int. J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"bbab393","DOI":"10.1093\/bib\/bbab393","article-title":"Representation of molecules for drug response prediction","volume":"23","author":"An","year":"2022","journal-title":"Brief. Bioinform"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-026-02710-8","article-title":"Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond","volume":"11","author":"Andersen","year":"2026","journal-title":"Signal Transduct. Target Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1200\/JCO.2026.44.2_suppl.28","article-title":"Clinical utility of the Idylla CDx MSI test in identifying MSI-H mCRC patients eligible for nivolumab monotherapy or in combination with ipilimumab therapy (CheckMate 8HW phase III trial)","volume":"44","author":"Andre","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s43441-025-00799-7","article-title":"Companion Diagnostic FDA Review Flexibilities: An Assessment of CDx for NSCLC to Support Aligned Approaches for Validation","volume":"59","author":"Andrews","year":"2025","journal-title":"Ther. Innov. Regul. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jjco\/hyad052","article-title":"Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance","volume":"53","author":"Araki","year":"2023","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/nar\/gky066","article-title":"Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics","volume":"46","author":"Ardui","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2024S117","DOI":"10.1590\/1806-9282.2024S117","article-title":"Importance of genetic cancer risk assessment as a strategy to stratify risk and provide precision prevention in high-risk patients and families","volume":"70","author":"Ashton-Prolla","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"key":"B18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/cimb47060470","article-title":"Integrating Artificial Intelligence in Next-Generation Sequencing: Advances, Challenges, and Future Directions","volume":"47","author":"Athanasopoulou","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2021.06.022","article-title":"Epigenetic Regulation of Cancer Immune Cells","volume":"83","author":"Avella","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bjc.2017.52","article-title":"Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system","volume":"116","author":"Bae","year":"2017","journal-title":"Br. J. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"jkad160","DOI":"10.1093\/g3journal\/jkad160","article-title":"Glyoxal as an alternative fixative for single-cell RNA sequencing","volume":"13","author":"Bageritz","year":"2023","journal-title":"G3 (Bethesda)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3332\/ecancer.2026.2071","article-title":"The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection","volume":"20","author":"Balch","year":"2026","journal-title":"Ecancermedicalscience"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1005725","DOI":"10.1371\/journal.pcbi.1005725","article-title":"Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity","volume":"13","author":"Bassani-Sternberg","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.lungcan.2021.10.007","article-title":"Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib","volume":"166","author":"Bauml","year":"2022","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1016\/S1470-2045(17)30373-X","article-title":"Genomic approaches to accelerate cancer interception","volume":"18","author":"Beane","year":"2017","journal-title":"Lancet Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40268-024-00478-2","article-title":"The importance of patient reported outcomes in oncology clinical trials and clinical practice to inform regulatory and healthcare decision-making","volume":"24","author":"Bellino","year":"2024","journal-title":"Drugs R. D."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1610607","DOI":"10.3389\/pore.2022.1610607","article-title":"EGFR T790M mutation detection in patients with non-small cell lung cancer after first line EGFR TKI therapy: summary of results in a three-year period and a comparison of commercially available detection kits","volume":"28","author":"Bencze","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"114440","DOI":"10.1016\/j.yexcr.2025.114440","article-title":"BRAF V600E in cancer: exploring structural complexities, mutation profiles, and pathway dysregulation","volume":"446","author":"Bharti","year":"2025","journal-title":"Exp. Cell Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/annonc\/mdv072","article-title":"A randomized phase II study of the MEK1\/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)","volume":"26","author":"Blumenschein","year":"2015","journal-title":"Ann. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41467-019-09637-5","article-title":"Sequencing of human genomes with nanopore technology","volume":"10","author":"Bowden","year":"2019","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4161\/cbt.11.9.15050","article-title":"Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab","volume":"11","author":"Brand","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15649","DOI":"10.1021\/acs.jmedchem.5c00576","article-title":"Discovery of BI-2493, a Pan-KRAS Inhibitor Showing In Vivo Efficacy","volume":"68","author":"Br\u00f6ker","year":"2025","journal-title":"J. Med. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T Cells and T-Cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/annonc\/mdz205","article-title":"Optimizing panel-based tumor mutational burden (TMB) measurement","volume":"30","author":"Budczies","year":"2019","journal-title":"Ann. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e000442","DOI":"10.1136\/esmoopen-2018-000442","article-title":"Implementing TMB measurement in clinical practice: considerations on assay requirements","volume":"4","author":"B\u00fcttner","year":"2019","journal-title":"ESMO Open"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.37349\/etat.2022.00102","article-title":"Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples","volume":"3","author":"Capone","year":"2022","journal-title":"Explor Target Antitumor Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"17588359221096878","DOI":"10.1177\/17588359221096878","article-title":"Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience","volume":"14","author":"Caputo","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2217\/fon-2020-1007","article-title":"MAHOGANY: margetuximab combination in HER2+ unresectable\/metastatic gastric\/gastroesophageal junction adenocarcinoma","volume":"17","author":"Catenacci","year":"2021","journal-title":"Future Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s1044-579x(02)00056-1","article-title":"BRCA1 methylation: a significant role in tumour development?","volume":"12","author":"Catteau","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/jcmm.70056","article-title":"Gene and cell therapy of human genetic diseases: Recent advances and future directions","volume":"28","author":"Cetin","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10238-024-01513-x","article-title":"Non-invasive early-stage cancer detection: current methods and future perspectives","volume":"25","author":"Chacko","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","article-title":"Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy","volume":"23","author":"Chehelgerdi","year":"2024","journal-title":"Mol. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"bbab378","DOI":"10.1093\/bib\/bbab378","article-title":"How much can deep learning improve prediction of the responses to drugs in cancer cell lines?","volume":"23","author":"Chen","year":"2022","journal-title":"Brief. Bioinform"},{"key":"B50","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3892\/ol.2021.12563","article-title":"The HOTAIR lncRNA: A remarkable oncogenic promoter in human cancer metastasis","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol. Lett."},{"key":"B51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol. Diagn Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1097\/CM9.0000000000003306","article-title":"Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed\/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cells","volume":"138","author":"Chen","year":"2024","journal-title":"Chin. Med. J. Engl."},{"key":"B53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn"},{"key":"B54","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/cancers15020504","article-title":"Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer","volume":"15","author":"Chhouri","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1038\/s41467-025-61597-1","article-title":"Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma","volume":"16","author":"Chung","year":"2025","journal-title":"Nat. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrg.2017.96","article-title":"Cancer transcriptome profiling at the juncture of clinical translation","volume":"19","author":"Cie\u015blik","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"18191","DOI":"10.1038\/s41598-024-68350-6","article-title":"Patient-centric thresholding of Cobas\u00ae EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer","volume":"14","author":"Claus","year":"2024","journal-title":"Sci. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1158\/1078-0432.CCR-22-1491","article-title":"Synthetic Biology in the Engineering of CAR-T and CAR-NK Cell Therapies: Facts and Hopes","volume":"29","author":"Clubb","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1304342","DOI":"10.3389\/fphar.2023.1304342","article-title":"Antisense oligonucleotides: a novel Frontier in pharmacological strategy","volume":"14","author":"Collotta","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1158\/1078-0432.CCR-23-0633","article-title":"Trastuzumab and Pertuzumab in Patients with Non-Breast\/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J","volume":"30","author":"Connolly","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0260089","DOI":"10.1371\/journal.pone.0260089","article-title":"A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors","volume":"16","author":"Conroy","year":"2021","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3791\/64242","article-title":"ATAC-seq Optimization for Cancer Epigenetics Research","volume":"30","author":"Cooper","year":"2022","journal-title":"J. Vis. Exp."},{"key":"B65","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: Mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1000667","DOI":"10.3389\/fgene.2022.1000667","article-title":"Polygenic risk scores: An overview from bench to bedside for personalised medicine","volume":"13","author":"Cross","year":"2022","journal-title":"Front. Genet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40487-021-00155-3","article-title":"Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"9","author":"Cruz","year":"2021","journal-title":"Oncol. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"884748","DOI":"10.3389\/fcell.2022.884748","article-title":"Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases","volume":"10","author":"Cuevas-Diaz","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.omtm.2025.101541","article-title":"Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager","volume":"33","author":"Currier","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1038\/s41467-025-60657-w","article-title":"Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies","volume":"16","author":"Damei","year":"2025","journal-title":"Nat. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"13219","DOI":"10.3390\/ijms241713219","article-title":"Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation","volume":"24","author":"Dao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/biologics3030011","article-title":"Precision Medicine in a Community Cancer Center: Pan-Cancer DNA\/RNA Sequencing of Tumors Reveals Clinically Relevant Gene Fusions","volume":"3","author":"Darabi","year":"2023","journal-title":"Biologics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/cancers18020327","article-title":"Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology","volume":"18","author":"Das","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.18632\/oncotarget.28757","article-title":"Comprehensive genomic profiling of over 10,000 advanced solid tumors","volume":"16","author":"De La","year":"2025","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-018-0776-2","article-title":"Role and targeting of anaplastic lymphoma kinase in cancer","volume":"17","author":"Della Corte","year":"2018","journal-title":"Mol. Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"17588359231186024","DOI":"10.1177\/17588359231186025","article-title":"Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study","volume":"15","author":"Deng","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21037\/atm.2018.06.10","article-title":"Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer","volume":"6","author":"Diamantopoulos","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12943-022-01559-z","article-title":"Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing","volume":"21","author":"Dimitri","year":"2022","journal-title":"Mol. Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"16325","DOI":"10.3390\/ijms242216325","article-title":"CRISPR\/Cas9-Mediated Genome Editing in Cancer Therapy","volume":"24","author":"Ding","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2147\/DDDT.S507402","article-title":"Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides","volume":"19","author":"Ding","year":"2025","journal-title":"Drug Des. Devel Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/febs.17003","article-title":"Tumor immune evasion: insights from CRISPR screens and future directions","volume":"291","author":"Djajawi","year":"2024","journal-title":"FEBS J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"642","DOI":"10.18632\/oncotarget.28761","article-title":"Clinical and analytical validation of MI Cancer Seek\u00ae, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay","volume":"16","author":"Domenyuk","year":"2025","journal-title":"Oncotarget"},{"key":"B86","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41416-023-02319-6","article-title":"Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer","volume":"129","author":"Dong","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","article-title":"Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(24)00319-2","article-title":"Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial","volume":"403","author":"D\u2019Angelo","year":"2024","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.3390\/ijms26083456","article-title":"Recent Update on siRNA Therapeutics","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"747-e218","DOI":"10.1634\/theoncologist.2018-0838","article-title":"An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma","volume":"24","author":"El","year":"2019","journal-title":"Oncologist"},{"key":"B91","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control Release"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1560778","DOI":"10.3389\/fimmu.2025.1560778","article-title":"Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging","volume":"16","author":"Eliason","year":"2025","journal-title":"Front. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.xcrm.2025.102353","article-title":"CAR-T cells in solid tumors: Challenges and breakthroughs","volume":"6","author":"Escobar","year":"2025","journal-title":"Cell Rep. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1158\/1538-7445.AM2024-5023","article-title":"Abstract 5023: analytical validation of the OncomineTM Dx express test using liquid biopsy samples as an IUO assay in a CAP\/CLIA lab","volume":"84","author":"Espinoza","year":"2024","journal-title":"Cancer Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65492-2","article-title":"hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis","volume":"155","author":"Esteller","year":"1999","journal-title":"Am. J. Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/cancers16071331","article-title":"Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art","volume":"16","author":"Fabrizio","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10549-013-2793-6","article-title":"Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy","volume":"143","author":"Fan","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/1538-7445.AM2013-3229","article-title":"Abstract 3229: validation of illumina truseq amplicon cancer panel with concordance testing using ion ampliseq cancer panel and other methods","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A roadmap to increase diversity in genomic studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/ajcp\/aqad148","article-title":"Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience","volume":"161","author":"Fei","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40164-024-00570-y","article-title":"CRISPR\/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications","volume":"13","author":"Feng","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9040300","article-title":"Human Papillomaviruses and Epstein-Barr Virus Interactions in Colorectal Cancer: A Brief Review","volume":"9","author":"Fernandes","year":"2020","journal-title":"Pathogens"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/cancers13061383","article-title":"Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma","volume":"13","author":"Ferrucci","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJMoa2214676","article-title":"Rucaparib or Physician\u2019s Choice in Metastatic Prostate Cancer","volume":"388","author":"Fizazi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/ijms22020612","article-title":"Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer","volume":"22","author":"Fois","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.17.541233","article-title":"A novel pan-RAS Inhibitor with a unique mechanism of action blocks tumor growth in mouse models of GI cancer","volume":"7","author":"Foote","year":"2024","journal-title":"bioRxiv"},{"key":"B109","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14737159.2020.1701438","article-title":"A profile on the FoundationFocus CDxBRCA tests","volume":"20","author":"Ford","year":"2020","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B110","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/cancers15235525","article-title":"Concordance between three homologous recombination deficiency (HRD) assays in patients with high-grade epithelial ovarian cancer","volume":"15","author":"Fountzilas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-3-031-06573-6_12","article-title":"Epigenetic-mediated regulation of gene expression for biological control and cancer: cell and tissue structure, function, and phenotype","volume":"70","author":"Fritz","year":"2022","journal-title":"Results Probl. Cell Differ."},{"key":"B112","doi-asserted-by":"publisher","first-page":"596445","DOI":"10.3389\/fmolb.2020.596445","article-title":"Erratum: a DNA methylation-based panel for the prognosis and diagnosis of patients with breast cancer and its mechanisms","volume":"7","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.3390\/jcm13216537","article-title":"Next-generation immunotherapy: advancing clinical applications in cancer treatment","volume":"13","author":"Garg","year":"2024","journal-title":"J. Clin. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ncrna11040053","article-title":"Direct circRNA-mRNA binding controls mRNA fate: a new mechanism for circRNAs","volume":"11","author":"Garraffo","year":"2025","journal-title":"Noncoding RNA"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e23601","DOI":"10.1002\/jcla.23601","article-title":"Identification of a stool long non-coding RNAs panel as a potential biomarker for early detection of colorectal cancer","volume":"35","author":"Gharib","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"B116","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12672-025-01816-9","article-title":"Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions","volume":"16","author":"Ghoreyshi","year":"2025","journal-title":"Discov. Oncology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1021\/acsbiomaterials.5c00121","article-title":"In Situ cancer vaccines: redefining immune activation in the tumor microenvironment","volume":"11","author":"Giram","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B118","doi-asserted-by":"publisher","first-page":"638-e952","DOI":"10.1093\/oncolo\/oyae096","article-title":"Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial","volume":"29","author":"Glade","year":"2024","journal-title":"Oncologist"},{"key":"B119","doi-asserted-by":"publisher","first-page":"24560","DOI":"10.18632\/oncotarget.4183","article-title":"RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients","volume":"6","author":"Golan","year":"2015","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/jpm11020142","article-title":"Identification of somatic structural variants in solid tumors by optical genome mapping","volume":"11","author":"Goldrich","year":"2021","journal-title":"J. Pers. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41573-025-01273-7","article-title":"Synthetic lethality in cancer drug discovery: challenges and opportunities","volume":"25","author":"Gon\u00e7alves","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"B122","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/noajnl\/vdaf087","article-title":"Redefining the immune microenvironment of gliomas in the era of single-cell genomics","volume":"8","author":"Gonzalez Castro","year":"2026","journal-title":"Neurooncol Adv."},{"key":"B123","doi-asserted-by":"publisher","first-page":"9952727","DOI":"10.1155\/tbj\/9952727","article-title":"Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research","volume":"2025","author":"Gorodetska","year":"2025","journal-title":"Breast J."},{"key":"B124","doi-asserted-by":"publisher","first-page":"102724","DOI":"10.1016\/j.ctrv.2024.102724","article-title":"Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer","volume":"126","author":"Grant","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","article-title":"Non-coding RNAs in cancer: platforms and strategies for investigating the genomic \u201cdark matter\u201d","volume":"39","author":"Grillone","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"152411","DOI":"10.1016\/j.seminoncol.2025.152411","article-title":"Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer","volume":"52","author":"Guirguis","year":"2025","journal-title":"Semin. Oncol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-17-0432","article-title":"Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.semcancer.2020.12.022","article-title":"Targeting epigenetic regulatory machinery to overcome cancer therapy resistance","volume":"83","author":"Guo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-981-13-8844-6_15","article-title":"Next-Generation sequencing and its application: empowering in public health beyond reality","author":"Gupta","year":"2019"},{"key":"B130","doi-asserted-by":"publisher","first-page":"15330338251339256","DOI":"10.1177\/15330338251339256","article-title":"miR-10b as a clinical marker and a therapeutic target for metastatic breast cancer","volume":"24","author":"Halim","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"key":"B131","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cancergen.2021.02.002","article-title":"Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma","author":"Hamid","year":"2021","journal-title":"Cancer Genet."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1552741","DOI":"10.3389\/fphar.2025.1552741","article-title":"CRISPR\/Cas9 technology in tumor research and drug development application progress and future prospects","volume":"16","author":"Han","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/2643-3230.BCD-23-0212","article-title":"Understanding mechanisms of response to CAR T-cell therapy through single-cell sequencing: insights and challenges","volume":"5","author":"Haradhvala","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"B134","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.clml.2021.07.016","article-title":"A phase 2 study of PNT2258 for treatment of relapsed or refractory B-Cell malignancies","volume":"21","author":"Harb","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"B135","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.21873\/anticanres.15907","article-title":"Significance of the multi-gene panel myRisk in Japan","volume":"42","author":"Hayashi","year":"2022","journal-title":"Anticancer Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"101357","DOI":"10.1016\/j.jpha.2025.101357","article-title":"CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability","volume":"16","author":"He","year":"2026","journal-title":"J. Pharm. Anal."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e2000504","DOI":"10.1200\/PO.20.00504","article-title":"Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing","volume":"6","author":"Hehir-Kwa","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1097\/AOG.0000000000003562","article-title":"Number 793","volume":"134","year":"2019","journal-title":"Obstetrics Gynecology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1552182","DOI":"10.3389\/fdgth.2025.1552182","article-title":"The impact of tele-expertise in oncology: current state and future perspectives","volume":"7","author":"Heudel","year":"2025","journal-title":"Front. Digit. Health"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/s41467-019-09374-9","article-title":"Diagnosis of fusion genes using targeted RNA sequencing","volume":"10","author":"Heyer","year":"2019","journal-title":"Nat. Commun."},{"key":"B141","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40259-024-00669-y","article-title":"Prospects of synergy: local interventions and CAR T cell therapy in solid tumors","volume":"38","author":"Holtermann","year":"2024","journal-title":"BioDrugs"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B143","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/diagnostics11020370","article-title":"Local laboratory testing of germline BRCA mutations vs. myriad: a single-institution experience in Korea","volume":"11","author":"Hong","year":"2021","journal-title":"Diagn. (Basel)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3390\/cancers13215364","article-title":"Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact","volume":"13","author":"Honor\u00e9","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0394632016686985","article-title":"Circular RNAs: An emerging type of RNA in cancer","volume":"30","author":"Hou","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1186\/1471-2407-14-820","article-title":"Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer","volume":"14","author":"Hu","year":"2014","journal-title":"BMC Cancer"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1691056","DOI":"10.3389\/fbinf.2025.1691056","article-title":"A novel and accelerated method for integrated alignment and variant calling from short and long reads","volume":"5","author":"Hu","year":"2025","journal-title":"Front. Bioinformatics"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111741","article-title":"Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B149","first-page":"7234","article-title":"Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bioactmat.2026.02.014","article-title":"Advances in delivery technologies-powered cancer vaccines","volume":"61","author":"Huang","year":"2026","journal-title":"Bioact. Mater"},{"key":"B152","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14796694.2024.2430725","article-title":"Potential barriers to implementation of next-generation sequencing in cancer management: a U.S. Physician-based survey","volume":"21","author":"Hussain","year":"2025","journal-title":"Future Oncol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1038\/s41467-024-52980-5","article-title":"Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones","volume":"15","author":"Ianevski","year":"2024","journal-title":"Nat. Commun."},{"key":"B154","volume-title":"Lynch Syndrome","author":"Idos","year":"1993"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3390\/diagnostics15192425","article-title":"Next-Generation Sequencing: A Review of Its Transformative Impact on Cancer Diagnosis, Treatment, and Resistance Management","volume":"15","author":"Isaic","year":"2025","journal-title":"Diagn. (Basel)"},{"key":"B156","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.gendis.2025.101880","article-title":"Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers","volume":"13","author":"Islam","year":"2026","journal-title":"Genes Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/atm-25-34","article-title":"Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment","volume":"13","author":"Jamalinia","year":"2025","journal-title":"Ann. Transl. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41416-022-01913-4","article-title":"Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing","volume":"127","author":"Jan","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B159","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","article-title":"High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis","volume":"14","author":"Janesick","year":"2023","journal-title":"Nat. Commun."},{"key":"B160","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2147\/CMAR.S421928","article-title":"Potential Diagnostic Utility of microRNAs in Gastrointestinal Cancers","volume":"15","author":"Jelski","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e2452661","DOI":"10.1001\/jamanetworkopen.2024.52661","article-title":"Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection","volume":"7","author":"Ji","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"B162","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1538-7445.AM2022-5795","article-title":"Abstract 5795: Validation of FDA approved oncoReveal Dx lung and colon cancer assay (oRDx-LCCA)","volume":"82","author":"Johnson","year":"2022","journal-title":"Cancer Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/ETLS20160025","article-title":"Computational biology: deep learning","volume":"1","author":"Jones","year":"2017","journal-title":"Emerg. Top. Life Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1038\/s41598-019-43282-8","article-title":"Deleterious effects of formalin-fixation and delays to fixation on RNA and miRNA-Seq profiles","volume":"9","author":"Jones","year":"2019","journal-title":"Sci. Rep."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/bioinformatics\/btac137","article-title":"BWA-MEME: BWA-MEM emulated with a machine learning approach","volume":"38","author":"Jung","year":"2022","journal-title":"Bioinformatics"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e0329946","DOI":"10.1371\/journal.pone.0329946","article-title":"a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity","volume":"20","author":"Jung","year":"2025","journal-title":"PLoS One"},{"key":"B167","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/cancers17122001","article-title":"Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors-Currents and Perspectives","volume":"17","author":"Kaczmarek","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B168","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pharma.2025.11.010","article-title":"Companion diagnostic: An overview of regulatory framework, challenges, and future directions","volume":"84","author":"Kadam","year":"2026","journal-title":"Ann. Pharm. Fr."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1200\/JCO-24-02086","article-title":"Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4\/6 Inhibition: Results From the Phase III postMONARCH Trial","volume":"43","author":"Kalinsky","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1683469","DOI":"10.3389\/fbinf.2025.1683469","article-title":"Role of histone-lysine N-methyltransferase 2D (KMT2D) in MEK-ERK signaling-mediated epigenetic regulation: a phosphoproteomics perspective","volume":"5","author":"Kammarambath","year":"2025","journal-title":"Front. Bioinformatics"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/life14111358","article-title":"Companion Diagnostics (CDx) Based on Molecular Biology Techniques","volume":"14","author":"Kang","year":"2024","journal-title":"Life (Basel)"},{"key":"B172","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/15578100251392371","article-title":"Integrative Multi-Omics and Artificial Intelligence: A New Paradigm for Systems Biology","volume":"29","author":"Kant","year":"2025","journal-title":"OMICS"},{"key":"B173","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.24.581875","article-title":"Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells","author":"Kasap","year":"2024","journal-title":"bioRxiv"},{"key":"B175","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jcyt.2024.02.014","article-title":"Therapeutic potential of CRISPR\/CAS9 genome modification in T cell-based immunotherapy of cancer","volume":"26","author":"Kavousinia","year":"2024","journal-title":"Cytotherapy"},{"key":"B176","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.3390\/ijms26104644","article-title":"ARID1A and Its Impact Across the Hallmarks of Cancer","volume":"26","author":"Kearns","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"oyag001","DOI":"10.1093\/oncolo\/oyag001","article-title":"DNA and RNA-based next-generation sequencing for companion diagnostic rearrangement detection in solid tumors","volume":"31","author":"Keller-Evans","year":"2026","journal-title":"Oncologist"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.1678","article-title":"Epigenetic modifications as therapeutic targets","volume":"28","author":"Kelly","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"e2275","DOI":"10.1002\/rmv.2275","article-title":"Long noncoding RNAs in respiratory viruses: A review","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.3390\/cancers17172810","article-title":"Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions","volume":"17","author":"Khelwatty","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B181","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s12276-024-01212-3","article-title":"Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ncrna.2017.06.002","article-title":"Small non-coding RNAs as regulators of structural evolution and carcinogenesis","volume":"2","author":"Klimenko","year":"2017","journal-title":"Noncoding RNA Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrclinonc.2013.46","article-title":"Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors","volume":"10","author":"Kochenderfer","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.rpor.2020.07.007","article-title":"cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?","volume":"25","author":"Kolenda","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"B185","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1158\/1078-0432.CCR-21-3405","article-title":"Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Na\u00efve Acute Myeloid Leukemia","volume":"28","author":"Konopleva","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/cancers17152453","article-title":"Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?","volume":"17","author":"Krupa","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B187","doi-asserted-by":"publisher","first-page":"eabb3945","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.4049\/jimmunol.1502024","article-title":"MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses","volume":"197","author":"Kunert","year":"2016","journal-title":"J. Immunol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"39736","DOI":"10.1038\/srep39736","article-title":"Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients","volume":"6","author":"Kuske","year":"2016","journal-title":"Sci. Rep."},{"key":"B190","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/pcm.2024","article-title":"Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm","volume":"2","author":"Lajmi","year":"2024","journal-title":"Camb. Prisms Precis. Medicine"},{"key":"B191","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.3390\/ijms241210079","article-title":"The Role of EMT-Related lncRNAs in Ovarian Cancer","volume":"24","author":"Lampropoulou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B193","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","article-title":"Circulating tumour cells for early detection of clinically relevant cancer","volume":"20","author":"Lawrence","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol. Cancer"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol."},{"key":"B196","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/fon-2023-0702","article-title":"Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients","volume":"20","author":"Lee","year":"2024","journal-title":"Future Oncol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ol.2022.13397","article-title":"EML4-ALK fusion gene in non-small cell lung cancer","volume":"24","author":"Lei","year":"2022","journal-title":"Oncol. Lett."},{"key":"B198","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jtho.2017.11.117","article-title":"Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project","volume":"13","author":"Letovanec","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"e138740","DOI":"10.1172\/JCI138740","article-title":"Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control","volume":"131","author":"Lhuillier","year":"2021","journal-title":"J. Clin. Invest."},{"key":"B200","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"B201","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1002\/mco2.766","article-title":"Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges","volume":"5","author":"Li","year":"2024","journal-title":"MedComm (Beijing)."},{"key":"B202","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00091","article-title":"Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue To Represent High-Quality Transcriptome From Frozen Tissue","volume":"2018","author":"Li","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1158\/0008-5472.CAN-20-0384","article-title":"Integrated Genomic Characterization of the Human Immunome in Cancer","volume":"80","author":"Li","year":"2020","journal-title":"Cancer Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.omto.2021.07.003","article-title":"CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells","volume":"22","author":"Li","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"B206","doi-asserted-by":"publisher","first-page":"20626","DOI":"10.1002\/cam4.6511","article-title":"A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"key":"B207","doi-asserted-by":"publisher","first-page":"100300","DOI":"10.1016\/j.xgen.2023.100300","article-title":"CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types","volume":"3","author":"Li","year":"2023","journal-title":"Cell Genomics"},{"key":"B208","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","article-title":"A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Genomics"},{"key":"B209","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomedicine"},{"key":"B210","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41698-026-01276-6","article-title":"The impact of AI on modern oncology from early detection to personalized cancer treatment","volume":"10","author":"Li","year":"2026","journal-title":"NPJ Precis. Oncol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s13402-026-01199-1","article-title":"Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy","volume":"49","author":"Li","year":"2026","journal-title":"Cell. Oncology Dordr. Neth."},{"key":"B212","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.bbrep.2023.101589","article-title":"Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics","volume":"37","author":"Liang","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"B213","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/life11090890","article-title":"Liquid Biopsy, ctDNA Diagnosis through NGS","volume":"11","author":"Lin","year":"2021","journal-title":"Life (Basel)"},{"key":"B214","doi-asserted-by":"publisher","first-page":"156046","DOI":"10.1016\/j.prp.2025.156046","article-title":"The paradoxical role of IFN-\u03b3 in cancer: Balancing immune activation and immune evasion","volume":"272","author":"Liu","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"B215","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cell.2017.01.014","article-title":"Applications of immunogenomics to cancer","volume":"168","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"B216","doi-asserted-by":"publisher","first-page":"871","DOI":"10.6004\/jnccn.2021.7044","article-title":"The future of parallel tumor and germline genetic testing: is there a role for all patients with cancer?","volume":"19","author":"Liu","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S1470-2045(20)30466-6","article-title":"Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study","volume":"21","author":"Liu","year":"2020","journal-title":"Lancet Oncol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1002\/mco2.292","article-title":"Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets","volume":"4","author":"Liu","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"B219","doi-asserted-by":"publisher","first-page":"04071","DOI":"10.7189\/jogh.15.04071","article-title":"Influence and role of polygenic risk score in the development of 32 complex diseases","volume":"15","author":"Liu","year":"2025","journal-title":"J. Glob. Health"},{"key":"B220","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7554\/eLife.58925","article-title":"Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions","volume":"9","author":"Lord","year":"2020","journal-title":"Elife"},{"key":"B221","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(25)00083-X","article-title":"Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial","volume":"26","author":"Lou","year":"2025","journal-title":"Lancet Oncol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/17460441.2017.1317244","article-title":"Applications of CRISPR genome editing technology in drug target identification and validation","volume":"12","author":"Lu","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"B223","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B226","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41392-022-01198-2","article-title":"A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B227","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B228","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","article-title":"The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"key":"B229","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.2174\/1381612820666140128213117","article-title":"MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers","volume":"20","author":"Macha","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"B230","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40364-021-00300-0","article-title":"The contribution of single-cell analysis of acute leukemia in the therapeutic strategy","volume":"9","author":"Madaci","year":"2021","journal-title":"Biomark. Res."},{"key":"B231","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.15190\/d.2014.18","article-title":"Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment","volume":"2","author":"Maheshwari","year":"2014","journal-title":"Discov. (Craiova)."},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25112692","article-title":"Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy","volume":"25","author":"Mainini","year":"2020","journal-title":"Molecules"},{"key":"B233","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"B234","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"B235","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.lungcan.2019.06.016","article-title":"Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer","volume":"134","author":"Manjunath","year":"2019","journal-title":"Lung Cancer"},{"key":"B236","doi-asserted-by":"publisher","first-page":"e2100378","DOI":"10.1200\/PO.21.00378","article-title":"Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules","volume":"6","author":"Manjunath","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tig.2007.12.007","article-title":"The impact of next-generation sequencing technology on genetics","volume":"24","author":"Mardis","year":"2008","journal-title":"Trends Genet."},{"key":"B238","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-anchem-062012-092628","article-title":"Next-generation sequencing platforms","volume":"6","author":"Mardis","year":"2013","journal-title":"Annu. Rev. Anal. Chem. Palo Alto Calif."},{"key":"B239","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"Marei","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"B241","doi-asserted-by":"publisher","first-page":"104097","DOI":"10.1016\/j.isci.2022.104097","article-title":"High-resolution Slide-seqV2 spatial transcriptomics enables discovery of disease-specific cell neighborhoods and pathways","volume":"25","author":"Marshall","year":"2022","journal-title":"iScience"},{"key":"B242","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat. Genet."},{"key":"B243","doi-asserted-by":"publisher","first-page":"e2300056","DOI":"10.1200\/GO.23.00056","article-title":"Improving Equity Across Cancer Care Continuum in Asia Pacific","volume":"9","author":"Martina","year":"2023","journal-title":"JCO Glob. Oncol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"44262","DOI":"10.1038\/s41598-025-27895-w","article-title":"Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer","volume":"15","author":"Mendiola","year":"2025","journal-title":"Sci. Rep."},{"key":"B245","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ncrna7040070","article-title":"Advances in Non-Coding RNA Sequencing","volume":"7","author":"Micheel","year":"2021","journal-title":"Noncoding RNA"},{"key":"B246","doi-asserted-by":"publisher","first-page":"e0264138","DOI":"10.1371\/journal.pone.0264138","article-title":"Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors","volume":"17","author":"Milbury","year":"2022","journal-title":"PLoS One"},{"key":"B247","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1177\/15353702231211861","article-title":"Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16","volume":"248","author":"Minhas","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B248","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12967-018-1733-y","article-title":"Implementing a comprehensive translational oncology platform: from molecular testing to actionability","volume":"16","author":"Mitri","year":"2018","journal-title":"J. Transl. Med."},{"key":"B249","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/biomedicines12122750","article-title":"Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives","volume":"12","author":"Molla","year":"2024","journal-title":"Biomedicines"},{"key":"B250","doi-asserted-by":"publisher","first-page":"13922","DOI":"10.3389\/abp.2025.13922","article-title":"Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research","volume":"72","author":"Molla Desta","year":"2025","journal-title":"Acta Biochim. Pol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"key":"B252","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/vaccines13090976","article-title":"Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer","volume":"13","author":"Moseman","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B253","doi-asserted-by":"publisher","first-page":"e0120232","DOI":"10.1371\/journal.pone.0120232","article-title":"Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas\u00ae 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting","volume":"10","author":"Mourah","year":"2015","journal-title":"PLoS One"},{"key":"B254","doi-asserted-by":"publisher","first-page":"11593","DOI":"10.1038\/s41467-025-66737-1","article-title":"Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors","volume":"16","author":"Murray","year":"2025","journal-title":"Nat. Commun."},{"key":"B255","first-page":"591","article-title":"Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia","volume":"58","author":"My\u00f6h\u00e4nen","year":"1998","journal-title":"Cancer Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1599753","DOI":"10.3389\/fonc.2025.1599753","article-title":"Personalized preventive medicine using genomic information: future perspective and corresponding research plan","volume":"15","author":"Narimatsu","year":"2025","journal-title":"Front. Oncol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.trecan.2021.01.007","article-title":"Leveraging Single-Cell Approaches in Cancer Precision Medicine","volume":"7","author":"Nath","year":"2021","journal-title":"Trends Cancer"},{"key":"B258","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12935-024-03612-x","article-title":"HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives","volume":"24","author":"Nazari","year":"2024","journal-title":"Cancer Cell Int."},{"key":"B259","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"B260","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"key":"B261","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00262-025-03992-7","article-title":"Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model","volume":"74","author":"Nguyen","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"B262","doi-asserted-by":"publisher","first-page":"114375","DOI":"10.1016\/j.isci.2025.114375","article-title":"Polygenic risk scores: Navigating the future of precision medicine through economic, ethical, and scientific advancements","volume":"29","author":"Nguyen","year":"2026","journal-title":"iScience"},{"key":"B263","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-020-00744-3","article-title":"Ancestry-specific predisposing germline variants in cancer","volume":"12","author":"Oak","year":"2020","journal-title":"Genome Med."},{"key":"B264","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41591-022-02155-w","article-title":"Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer","volume":"29","author":"Ogier du Terrail","year":"2023","journal-title":"Nat. Med."},{"key":"B265","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S2352-3026(18)30021-8","article-title":"Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1\/1b trial","volume":"5","author":"Ohanian","year":"2018","journal-title":"Lancet Haematol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00438-025-02314-x","article-title":"Bioinformatics and artificial intelligence in genomic data analysis: current advances and future directions","volume":"300","author":"Olawade","year":"2025","journal-title":"Mol. Genet. Genomics"},{"key":"B267","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.3390\/curroncol29070382","article-title":"Real-world clinical outcomes after genomic profiling of circulating tumor DNA in patients with previously treated advanced non-small cell lung cancer","volume":"29","author":"Olsen","year":"2022","journal-title":"Curr. Oncol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1121020","DOI":"10.3389\/fmed.2023.1121020","article-title":"Anti-ROR1 CAR-T cells: architecture and performance","volume":"10","author":"Osorio-Rodr\u00edguez","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B269","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10142-024-01417-9","article-title":"The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution","volume":"24","author":"Ozcelik","year":"2024","journal-title":"Funct. Integr. Genomics"},{"key":"B270","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B271","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12859-023-05292-2","article-title":"Accelerating genomic workflows using NVIDIA Parabricks","volume":"24","author":"O\u2019Connell","year":"2023","journal-title":"BMC Bioinforma."},{"key":"B272","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41591-023-02379-4","article-title":"The NCI-MATCH trial: lessons for precision oncology","volume":"29","author":"O\u2019Dwyer","year":"2023","journal-title":"Nat. Med."},{"key":"B273","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-1-61779-316-5_20","article-title":"Using ChIP-seq technology to generate high-resolution profiles of histone modifications","volume":"791","author":"O\u2019Geen","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-016-1053-z","article-title":"Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study","volume":"14","author":"Palomba","year":"2016","journal-title":"J. Transl. Med."},{"key":"B275","doi-asserted-by":"publisher","first-page":"201037","DOI":"10.1016\/j.omton.2025.201037","article-title":"Perturbed CD81 in lung-cancer-derived extracellular vesicles modifies its function in cancer pathophysiology","volume":"33","author":"Paramanantham","year":"2025","journal-title":"Mol. Therapy Oncol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/cancers17060977","article-title":"Liquid Biopsy in HPV-Associated Head and Neck Cancer: A Comprehensive Review","volume":"17","author":"Parisi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B277","doi-asserted-by":"publisher","first-page":"161","DOI":"10.11613\/BM.2015.017","article-title":"Aberrant methylation patterns in cancer: a clinical view","volume":"25","author":"Paska","year":"2015","journal-title":"Biochem. Med. Zagreb."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1158\/1078-0432.CCR-15-1718","article-title":"A First-in-human phase I study of the oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with advanced Cancer","volume":"22","author":"Patnaik","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B279","doi-asserted-by":"publisher","first-page":"e100836","DOI":"10.15252\/embj.2018100836","article-title":"Past, present, and future of circRNAs","volume":"38","author":"Patop","year":"2019","journal-title":"EMBO J."},{"key":"B280","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-23-0795","article-title":"Early changes in circulating cell-free KRAS G12C predict response to adagrasib in KRAS mutant non-small cell lung cancer patients","volume":"29","author":"Paweletz","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B281","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch syndrome genetics and clinical implications","volume":"164","author":"Peltom\u00e4ki","year":"2023","journal-title":"Gastroenterology"},{"key":"B282","doi-asserted-by":"publisher","first-page":"965628","DOI":"10.3389\/fonc.2022.965628","article-title":"Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma","volume":"12","author":"Pe\u00f1a-Flores","year":"2022","journal-title":"Front. Oncol."},{"key":"B283","doi-asserted-by":"publisher","first-page":"763790","DOI":"10.3389\/fonc.2021.763790","article-title":"Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Oncol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1039\/c5cs00705d","article-title":"The challenges for cancer chemoprevention","volume":"44","author":"Penny","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"B285","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41698-024-00728-1","article-title":"Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics","volume":"8","author":"Pinkney","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.e15047","article-title":"Analytical validation and clinical performance of a plasma-based CGP assay, NEO | PanTracer LBx","volume":"43","author":"Pipinikas","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"B287","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","article-title":"Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease","volume":"19","author":"Piwecka","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"B288","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa2400985","article-title":"Brigatinib in NF2-related schwannomatosis with progressive tumors","volume":"390","author":"Plotkin","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B289","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/10408363.2023.2234488","article-title":"Hereditary breast and ovarian cancer: from genes to molecular targeted therapies","volume":"60","author":"Ponti","year":"2023","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B290","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A universal SNP and small-indel variant caller using deep neural networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B291","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","article-title":"Molecular Pathways and Mechanisms of BRAF in Cancer Therapy","volume":"28","author":"Poulikakos","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"B292","doi-asserted-by":"publisher","first-page":"a016600","DOI":"10.1101\/cshperspect.a016600","article-title":"Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins","volume":"7","author":"Prakash","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071823","article-title":"BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions","volume":"12","author":"Proietti","year":"","journal-title":"Cancers (Basel)"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102801","article-title":"Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review","volume":"12","author":"Proietti","year":"","journal-title":"Cancers (Basel)"},{"key":"B295","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13045-023-01491-9","article-title":"CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1200\/JCO.23.02314","article-title":"Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials","volume":"42","author":"Qi","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"B297","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(25)00860-8","article-title":"Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician\u2019s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial","volume":"405","author":"Qi","year":"","journal-title":"Lancet"},{"key":"B298","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5858\/arpa.2024-0014-OA","article-title":"Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies","volume":"149","author":"Qi","year":"","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B299","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jmoldx.2024.11.006","article-title":"Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01\/02","volume":"27","author":"Qi","year":"","journal-title":"J. Mol. Diagn"},{"key":"B300","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.tibtech.2022.02.004","article-title":"Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications","volume":"40","author":"Radfar","year":"2022","journal-title":"Trends Biotechnol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.3390\/cancers17172898","article-title":"Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions","volume":"17","author":"Rafii","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B302","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11899-017-0418-6","article-title":"Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia","volume":"12","author":"Ragon","year":"2017","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"B303","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12859-021-04311-4","article-title":"HELLO: improved neural network architectures and methodologies for small variant calling","volume":"22","author":"Ramachandran","year":"2021","journal-title":"BMC Bioinforma."},{"key":"B304","doi-asserted-by":"publisher","first-page":"e47114","DOI":"10.1097\/MD.0000000000047114","article-title":"CRISPR\/CAS9-based gene editing in cancer therapy: A systematic review and meta-analysis on current status and future directions","volume":"105","author":"Rehman","year":"2026","journal-title":"Medicine"},{"key":"B305","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"key":"B306","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"B307","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41420-021-00485-1","article-title":"Single cell RNA sequencing for breast cancer: present and future","volume":"7","author":"Ren","year":"2021","journal-title":"Cell Death Discov."},{"key":"B308","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-025-02167-1","article-title":"Cancer chemoprevention: signaling pathways and strategic approaches","volume":"10","author":"Ren","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B309","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S1470-2045(20)30533-7","article-title":"Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III\/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"21","author":"Rocconi","year":"2020","journal-title":"Lancet Oncol."},{"key":"B311","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cllc.2023.12.010","article-title":"STAR-121: a phase III randomized study of domvanalimab and zimberelimab in combination with chemotherapy versus pembrolizumab with chemotherapy in untreated metastatic non-small cell lung cancer with no actionable gene alterations","volume":"25","author":"Rodriguez-Abreu","year":"2024","journal-title":"Clin. Lung Cancer"},{"key":"B312","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaw1219","article-title":"Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution","volume":"363","author":"Rodriques","year":"2019","journal-title":"Science"},{"key":"B313","doi-asserted-by":"publisher","first-page":"105068","DOI":"10.1016\/j.critrevonc.2025.105068","article-title":"The role of therapeutic cancer vaccines in the modern immunotherapy era: State of the art with recent progress and future challenges","volume":"217","author":"Rota","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/diagnostics16040523","article-title":"The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology","volume":"16","author":"Rouvinov","year":"2026","journal-title":"Diagn. (Basel)"},{"key":"B315","doi-asserted-by":"publisher","first-page":"1807704","DOI":"10.3389\/fonc.2026.1807704","article-title":"Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review","volume":"16","author":"Ruge","year":"2026","journal-title":"Front. Oncol."},{"key":"B316","doi-asserted-by":"publisher","first-page":"107715","DOI":"10.1016\/j.pharmthera.2020.107715","article-title":"Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers","volume":"220","author":"Saaoud","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B317","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"B318","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat. Genet."},{"key":"B319","doi-asserted-by":"publisher","first-page":"2206725","DOI":"10.1080\/2162402X.2023.2206725","article-title":"Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer","volume":"12","author":"Sandstr\u00f6m Gerdtsson","year":"2023","journal-title":"Oncoimmunology"},{"key":"B320","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B321","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4049\/jimmunol.1701024","article-title":"Dendritic Cell-Based Cancer Vaccines","volume":"200","author":"Santos","year":"2018","journal-title":"J. Immunol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"11102","DOI":"10.3390\/ijms222011102","article-title":"BET Proteins as Attractive Targets for Cancer Therapeutics","volume":"22","author":"Sarnik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B323","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/biology12070997","article-title":"Next-Generation Sequencing Technology: Current Trends and Advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biol. (Basel)"},{"key":"B324","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1042\/BST0370918","article-title":"miR-21 as a key regulator of oncogenic processes","volume":"37","author":"Selcuklu","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"B325","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"B326","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells13010047","article-title":"Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications","volume":"13","author":"Shaban","year":"2023","journal-title":"Cells"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.08.584100","article-title":"Automated Identification of germline de novo mutations in family trios: a consensus-based informatic approach","author":"Shadrina","year":"2024","journal-title":"bioRxiv"},{"key":"B328","doi-asserted-by":"publisher","first-page":"9343","DOI":"10.1038\/s41467-024-53374-3","article-title":"Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope","volume":"15","author":"Shafighi","year":"2024","journal-title":"Nat. Commun."},{"key":"B329","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/ITT.S288546","article-title":"Targeting CD22 for the treatment of B-cell malignancies","volume":"10","author":"Shah","year":"2021","journal-title":"Immunotargets Ther."},{"key":"B330","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1200\/JCO-24-02158","article-title":"Phase I\/II Study of Adaptive Manufactured Lentiviral Anti-CD20\/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma","volume":"43","author":"Shah","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.xcrm.2022.100861","article-title":"AI in medicine: Where are we now and where are we going?","volume":"3","author":"Shandhi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"B332","doi-asserted-by":"publisher","first-page":"1309175","DOI":"10.3389\/fgene.2024.1309175","article-title":"Engineering CRISPR\/Cas9 therapeutics for cancer precision medicine","volume":"15","author":"Sharma","year":"2024","journal-title":"Front. Genet."},{"key":"B333","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40291-016-0193-4","article-title":"Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer","volume":"20","author":"Sharma","year":"2016","journal-title":"Mol. Diagn Ther."},{"key":"B334","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/s41598-023-29644-3","article-title":"DeepInsight-3D architecture for anti-cancer drug response prediction with deep-learning on multi-omics","volume":"13","author":"Sharma","year":"2023","journal-title":"Sci. Rep."},{"key":"B335","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s10038-024-01231-y","article-title":"Advances in AI and machine learning for predictive medicine","volume":"69","author":"Sharma","year":"2024","journal-title":"J. Hum. Genet."},{"key":"B336","doi-asserted-by":"publisher","first-page":"679117","DOI":"10.3389\/fimmu.2021.679117","article-title":"Natural killer cells: the linchpin for successful cancer immunotherapy","volume":"12","author":"Shaver","year":"2021","journal-title":"Front. Immunol."},{"key":"B337","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/1940-6207.CAPR-15-0349","article-title":"DNA hypomethylation contributes to genomic instability and intestinal cancer initiation","volume":"9","author":"Sheaffer","year":"2016","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"B338","doi-asserted-by":"publisher","first-page":"106838","DOI":"10.5306\/wjco.v16.i8.106838","article-title":"Cell reprogramming in cancer: Interplay of genetic, epigenetic mechanisms, and the tumor microenvironment in carcinogenesis and metastasis","volume":"16","author":"Shenoy","year":"2025","journal-title":"World J. Clin. Oncol."},{"key":"B339","doi-asserted-by":"publisher","first-page":"1649468","DOI":"10.3389\/fimmu.2025.1649468","article-title":"Single-cell and spatial transcriptomics integration: new frontiers in tumor microenvironment and cellular communication","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"B340","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune Checkpoint Inhibitors in Cancer Therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"key":"B341","doi-asserted-by":"publisher","first-page":"100842","DOI":"10.1016\/j.xgen.2025.100842","article-title":"Single-cell meta-analysis of T cells reveals clonal dynamics of response to checkpoint immunotherapy","volume":"5","author":"Shorer","year":"2025","journal-title":"Cell Genomics"},{"key":"B342","doi-asserted-by":"publisher","first-page":"e0292251","DOI":"10.1371\/journal.pone.0292251","article-title":"Performance of the cobas EZH2 mutation test on clinical samples from non-Hodgkin lymphoma patients","volume":"18","author":"Shyu","year":"2023","journal-title":"PLoS One"},{"key":"B343","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1038\/s41591-025-03848-8","article-title":"Clinical utility of targeted RNA sequencing in cancer molecular diagnostics","volume":"31","author":"Siddaway","year":"2025","journal-title":"Nat. Med."},{"key":"B344","first-page":"265","article-title":"MicroRNA Significance in Cancer: An Updated Review on Diagnostic, Prognostic, and Therapeutic Perspectives","volume":"35","author":"Singh","year":"2024","journal-title":"EJIFCC"},{"key":"B345","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/bdrc.20199","article-title":"Role of epigenetics in developmental biology and transgenerational inheritance","volume":"93","author":"Skinner","year":"2011","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"B346","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The Role of Non-coding RNAs in Oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"B347","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"B348","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jmoldx.2013.10.001","article-title":"Efficient identification of miRNAs for classification of tumor origin","volume":"16","author":"S\u00f8kilde","year":"2014","journal-title":"J. Mol. Diagn"},{"key":"B349","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/pmic.202400011","article-title":"Key Considerations on CITE-Seq for Single-Cell Multiomics","volume":"25","author":"Song","year":"2025","journal-title":"Proteomics"},{"key":"B350","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12962-019-0191-6","article-title":"Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment","volume":"17","author":"Spizzo","year":"2019","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"B351","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid. Ther."},{"key":"B352","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/cancers17172866","article-title":"Revolutionizing Oncology Through AI: Addressing Cancer Disparities by Improving Screening, Treatment, and Survival Outcomes via Integration of Social Determinants of Health","volume":"17","author":"Srivastav","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B353","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2020.11.005","article-title":"Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade","volume":"39","author":"Srivastava","year":"2021","journal-title":"Cancer Cell"},{"key":"B354","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1200\/JCO.2013.49.7271","article-title":"Cancer genomics and inherited risk","volume":"32","author":"Stadler","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B355","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1182\/bloodadvances.2019000194","article-title":"Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma","volume":"3","author":"Stadtmauer","year":"2019","journal-title":"Blood Adv."},{"key":"B356","doi-asserted-by":"publisher","first-page":"10743","DOI":"10.1038\/s41467-024-53220-6","article-title":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial","volume":"15","author":"Stein","year":"2024","journal-title":"Nat. Commun."},{"key":"B357","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ctrv.2023.102649","article-title":"Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing","volume":"122","author":"Stenzinger","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"B358","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1073\/pnas.1712064115","article-title":"Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance","volume":"114","author":"Su","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B359","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.2169\/internalmedicine.1110-22","article-title":"Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer","volume":"62","author":"Sumii","year":"2023","journal-title":"Intern Med."},{"key":"B360","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B361","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-022-01553-5","article-title":"Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses","volume":"21","author":"Suvilesh","year":"2022","journal-title":"Mol. Cancer"},{"key":"B362","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.trecan.2023.01.004","article-title":"Preclinical models to study patient-derived circulating tumor cells and metastasis","volume":"9","author":"Suvilesh","year":"2023","journal-title":"Trends Cancer"},{"key":"B363","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1158\/1078-0432.CCR-23-3980","article-title":"Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids","volume":"30","author":"Suvilesh","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"B364","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"B365","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.1016\/j.cels.2025.101266","article-title":"Joint analysis of chromatin accessibility and gene expression in the same single cells reveals cancer-specific regulatory programs","volume":"16","author":"Tang","year":"2025","journal-title":"Cell Syst."},{"key":"B366","doi-asserted-by":"publisher","first-page":"1354825","DOI":"10.3389\/fimmu.2024.1354825","article-title":"Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR\/Cas9 gene editing technology","volume":"15","author":"Tao","year":"2024","journal-title":"Front. Immunol."},{"key":"B367","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1158\/1535-7163.MCT-24-0386","article-title":"Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification","volume":"24","author":"Tedeschi","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"B368","doi-asserted-by":"publisher","first-page":"422","DOI":"10.18632\/oncotarget.27894","article-title":"Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology","volume":"12","author":"Telford","year":"2021","journal-title":"Oncotarget"},{"key":"B369","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1476-5381.2010.01188.x","article-title":"The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells","volume":"162","author":"Tiffon","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B370","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","article-title":"Non-coding RNAs as liquid biopsy biomarkers in cancer","volume":"126","author":"Toden","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B371","doi-asserted-by":"publisher","first-page":"e007554","DOI":"10.1136\/jitc-2023-007554","article-title":"Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer","volume":"11","author":"Toffoli","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"B372","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa2508668","article-title":"Trastuzumab deruxtecan plus pertuzumab for HER2-positive metastatic breast cancer","volume":"29","author":"Tolaney","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B373","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol. Pozn."},{"key":"B374","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1182\/blood.V122.21.2617.2617","article-title":"Development and validation of highly sensitive Mrdx BCR-ABL test for monitoring deep molecular response in patients with chronic myeloid leukemia","volume":"122","author":"Toplin","year":"2013","journal-title":"Blood"},{"key":"B375","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060778","article-title":"HOTAIR as a Prognostic Predictor for Diverse Human Cancers: A Meta- and Bioinformatics Analysis","volume":"11","author":"Toy","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B376","doi-asserted-by":"publisher","first-page":"101064","DOI":"10.1016\/j.currproblcancer.2024.101064","article-title":"Current management of uncommon EGFR mutations in non-small cell lung cancer","volume":"49","author":"Trinh","year":"2024","journal-title":"Curr. Probl. Cancer"},{"key":"B377","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ncrna.2017.06.003","article-title":"Unraveling long non-coding RNAs through analysis of high-throughput RNA-sequencing data","volume":"2","author":"Tripathi","year":"2017","journal-title":"Noncoding RNA Res."},{"key":"B378","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13053-023-00266-0","article-title":"Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria","volume":"21","author":"Trujillo-Rojas","year":"2023","journal-title":"Hered. Cancer Clin. Pract."},{"key":"B379","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/cclm-2013-0883","article-title":"Routine use of the Ion Torrent AmpliSeqTM Cancer Hotspot Panel for identification of clinically actionable somatic mutations","volume":"52","author":"Tsongalis","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"B380","doi-asserted-by":"publisher","DOI":"10.3390\/ht6030012","article-title":"High-throughput methods to detect long non-coding RNAs","volume":"6","author":"Uchida","year":"2017","journal-title":"High. Throughput"},{"key":"B381","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jmoldx.2019.09.009","article-title":"Development and analytical validation of a DNA dual-strand approach for the US food and drug administration-approved next-generation sequencing-based praxis extended RAS panel for metastatic colorectal cancer samples","volume":"22","author":"Udar","year":"2020","journal-title":"J. Mol. Diagn"},{"key":"B382","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl. Oncol."},{"key":"B383","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/PGPM.S156672","article-title":"ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients","volume":"11","author":"Uruga","year":"2018","journal-title":"Pharmgenomics Pers. Med."},{"key":"B384","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/c8lc00684a","article-title":"Cancer diagnosis: from tumor to liquid biopsy and beyond","volume":"19","author":"Vaidyanathan","year":"2018","journal-title":"Lab. Chip"},{"key":"B385","doi-asserted-by":"publisher","first-page":"11772719211047764","DOI":"10.1177\/11772719211047763","article-title":"Companion diagnostics: state of the art and new regulations","volume":"16","author":"Valla","year":"2021","journal-title":"Biomark. Insights"},{"key":"B386","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/1538-7445.AM2024-1771","article-title":"Abstract 1771: NYU langone genome PACT - genome profiling of actionable cancer targets (LG-PACT) for clinical patient molecular diagnostics and treatment","volume":"84","author":"Vasudevaraja","year":"2024","journal-title":"Cancer Res."},{"key":"B387","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/2159-8290.CD-NB2016-054","volume":"6","year":"2016","journal-title":"Cancer Discov."},{"key":"B388","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"B389","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3390\/cancers17193111","article-title":"EZH2 Dysregulation and its oncogenic role in human cancers","volume":"17","author":"Verma","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B390","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2353\/ajpath.2009.080794","article-title":"MiRNAs and cancer","volume":"174","author":"Visone","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B391","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/proteomes12030025","article-title":"Transforming clinical research: the power of high-throughput omics integration","volume":"12","author":"Vitorino","year":"2024","journal-title":"Proteomes"},{"key":"B392","doi-asserted-by":"publisher","first-page":"btad184","DOI":"10.1093\/bioinformatics\/btad184","article-title":"methylR: a graphical interface for comprehensive DNA methylation array data analysis","volume":"39","author":"Volpe","year":"2023","journal-title":"Bioinformatics"},{"key":"B393","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1182\/bloodadvances.2021004233","article-title":"Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)","volume":"5","author":"Walker","year":"2021","journal-title":"Blood Adv."},{"key":"B394","doi-asserted-by":"publisher","first-page":"e2000024","DOI":"10.1002\/bies.202000024","article-title":"Why the outcome of anti-tumor immune responses is heterogeneous: a novel idea in the context of immunological heterogeneity in cancers","volume":"42","author":"Wang","year":"2020","journal-title":"Bioessays"},{"key":"B395","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/mr-2021-0025","article-title":"Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention","volume":"1","author":"Wang","year":"2021","journal-title":"Med. Review"},{"key":"B396","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/s41416-024-02856-8","article-title":"Deep learning analysis of histopathological images predicts immunotherapy prognosis and reveals tumour microenvironment features in non-small cell lung cancer","volume":"131","author":"Wang","year":"","journal-title":"Br. J. Cancer"},{"key":"B397","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-024-07894-z","article-title":"A pathology foundation model for cancer diagnosis and prognosis prediction","volume":"634","author":"Wang","year":"2024","journal-title":"Nature"},{"key":"B398","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ajhg.2024.04.002","article-title":"Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds","volume":"111","author":"Wang","year":"","journal-title":"Am. J. Hum. Genet."},{"key":"B399","doi-asserted-by":"publisher","first-page":"e70460","DOI":"10.1002\/mco2.70460","article-title":"Artificial intelligence for the diagnosis and management of cancers: potentials and challenges","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm (Beijing)."},{"key":"B400","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/OTT.S81995","article-title":"Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making","volume":"8","author":"Weiss","year":"2015","journal-title":"Onco Targets Ther."},{"key":"B401","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.70197","article-title":"DNA methyltransferase inhibitors in hematological malignancies and solid tumors","volume":"158","author":"Wenger","year":"2026","journal-title":"Int. J. Cancer"},{"key":"B402","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/0008-5472.CAN-22-2794","article-title":"Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases","volume":"83","author":"Wood","year":"2023","journal-title":"Cancer Res."},{"key":"B403","doi-asserted-by":"publisher","first-page":"e0237802","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS One"},{"key":"B404","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10238-025-01987-3","article-title":"Multi-omics profiling and AI-driven clinically deployable risk models in MGUS and smoldering myeloma","volume":"26","author":"Wu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B405","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/jpm15100474","article-title":"Personalizing DNA cancer vaccines","volume":"15","author":"Wu","year":"2025","journal-title":"J. Pers. Med."},{"key":"B406","doi-asserted-by":"publisher","first-page":"19490","DOI":"10.1073\/pnas.1912459116","article-title":"Spatial transcriptome profiling by MERFISH reveals subcellular RNA compartmentalization and cell cycle-dependent gene expression","volume":"116","author":"Xia","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B407","doi-asserted-by":"publisher","first-page":"bbab356","DOI":"10.1093\/bib\/bbab356","article-title":"A cross-study analysis of drug response prediction in cancer cell lines","volume":"23","author":"Xia","year":"2022","journal-title":"Brief. Bioinform"},{"key":"B408","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-024-01987-z","article-title":"Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies","volume":"23","author":"Xiang","year":"2024","journal-title":"Mol. Cancer"},{"key":"B409","doi-asserted-by":"publisher","first-page":"15330338251401264","DOI":"10.1177\/15330338251401265","article-title":"Immunological and prognostic profiling of triple-negative breast cancer based on single-cell and bulk RNA sequencing of T-Cell exhaustion","volume":"24","author":"Xiao","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"key":"B410","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clml.2014.04.010","article-title":"Comparison between decitabine and azacitidine for the treatment of myelodysplastic syndrome: a meta-analysis with 1,392 participants","volume":"15","author":"Xie","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"B411","doi-asserted-by":"publisher","first-page":"25408","DOI":"10.18632\/oncotarget.8323","article-title":"Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"B412","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.3390\/ijms22073295","article-title":"Recent advances in oligonucleotide therapeutics in oncology","volume":"22","author":"Xiong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B413","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","article-title":"Genome sequencing analysis identifies epstein-barr virus subtypes associated with high risk of nasopharyngeal carcinoma","volume":"51","author":"Xu","year":"2019","journal-title":"Nat. Genet."},{"key":"B414","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.21037\/tcr-21-747","article-title":"A seven-lncRNA signature for predicting prognosis in breast carcinoma","volume":"10","author":"Xu","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"B415","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41586-024-07441-w","article-title":"A whole-slide foundation model for digital pathology from real-world data","volume":"630","author":"Xu","year":"2024","journal-title":"Nature"},{"key":"B416","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2025.5788","article-title":"Functional mechanisms of circular RNA-encoded peptides and future research strategies and directions in nasopharyngeal carcinoma","volume":"67","author":"Xu","year":"2025","journal-title":"Int. J. Oncol."},{"key":"B417","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.21037\/apm-19-643","article-title":"Effect of alectinib versus crizotinib on progression-free survival, central nervous system efficacy and adverse events in ALK-positive non-small cell lung cancer: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B418","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1038\/s41467-022-31827-x","article-title":"DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"B419","doi-asserted-by":"publisher","first-page":"9156","DOI":"10.1002\/cam4.5654","article-title":"RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med."},{"key":"B420","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12964-024-01698-4","article-title":"BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B421","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMoa2503001","article-title":"Overall survival with Amivantamab-Lazertinib in EGFR-mutated advanced NSCLC","volume":"393","author":"Yang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B422","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061706","article-title":"High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis","volume":"19","author":"Yeo-Teh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B423","doi-asserted-by":"publisher","first-page":"650795","DOI":"10.3389\/fgene.2021.650795","article-title":"SMIXnorm: fast and accurate RNA-Seq data normalization for formalin-fixed paraffin-embedded samples","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Genet."},{"key":"B424","doi-asserted-by":"publisher","first-page":"626659","DOI":"10.3389\/fonc.2021.626659","article-title":"Characterization and establishment of a Novel EBV strain simultaneously associated with nasopharyngeal carcinoma and b-cell lymphoma","volume":"11","author":"Yu","year":"2021","journal-title":"Front. Oncol."},{"key":"B425","doi-asserted-by":"publisher","first-page":"1420190","DOI":"10.3389\/fgene.2024.1420190","article-title":"Next-generation sequencing impact on cancer care: applications, challenges, and future directions","volume":"15","author":"Zalis","year":"2024","journal-title":"Front. Genet."},{"key":"B426","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.tibtech.2020.10.010","article-title":"Next-generation CRISPR technologies and their applications in gene and cell therapy","volume":"39","author":"Zeballos","year":"2021","journal-title":"Trends Biotechnol."},{"key":"B427","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/fon-2022-1237","article-title":"STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2","volume":"19","author":"Zeidan","year":"2023","journal-title":"Future Oncol."},{"key":"B428","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol. Cancer"},{"key":"B429","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12967-025-06486-3","article-title":"Advances in tumor subclone formation and mechanisms of growth and invasion","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"B430","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-12-1587","article-title":"Meta-analysis of the prognostic value of circulating tumor cells in breast cancer","volume":"18","author":"Zhang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B431","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225573","article-title":"Mechanisms and functions of long non-coding RNAs at multiple regulatory levels","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B432","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1038\/s41467-021-22872-z","article-title":"Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"B433","doi-asserted-by":"publisher","first-page":"672356","DOI":"10.3389\/fimmu.2021.672356","article-title":"Neoantigen: a new breakthrough in tumor immunotherapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"B434","doi-asserted-by":"publisher","first-page":"837","DOI":"10.32604\/or.2024.053882","article-title":"The regulatory role of lncRNA in tumor drug resistance: refracting light through a narrow aperture","volume":"33","author":"Zhang","year":"2025","journal-title":"Oncol. Res."},{"key":"B435","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12967-025-06732-8","article-title":"Functions and mechanisms of lncRNAs in immune escape and their application in immunotherapy for colorectal cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"B436","doi-asserted-by":"publisher","first-page":"101239","DOI":"10.1016\/j.gendis.2024.101239","article-title":"Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment","volume":"12","author":"Zhang","year":"2025","journal-title":"Genes Dis."},{"key":"B437","doi-asserted-by":"publisher","first-page":"1617654","DOI":"10.3389\/fimmu.2025.1617654","article-title":"Advances and challenges in neoantigen prediction for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"B438","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40779-025-00680-6","article-title":"Artificial intelligence in digital pathology diagnosis and analysis: technologies, challenges, and future prospects","volume":"12","author":"Zhang","year":"2026","journal-title":"Mil. Med. Res."},{"key":"B439","doi-asserted-by":"publisher","first-page":"14506","DOI":"10.18632\/aging.103496","article-title":"Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"key":"B440","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.7150\/jca.101042","article-title":"Integrating bulk and single-cell RNA-seq to construct a macrophage-related prognostic model for prognostic stratification in triple-negative breast cancer","volume":"15","author":"Zhao","year":"2024","journal-title":"J. Cancer"},{"key":"B441","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12939-026-02800-7","article-title":"Racial, ethnic, gender and age representation of clinical trials supporting FDA approval of cancer therapies","volume":"25","author":"Zhao","year":"2026","journal-title":"Int. J. Equity Health"},{"key":"B442","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1515\/mr-2023-0070","article-title":"New era of cancer immunology driven by big data","volume":"3","author":"Zheng","year":"2021","journal-title":"Med. Review"},{"key":"B443","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1002\/mco2.316","article-title":"Nanopore sequencing technology and its applications","volume":"4","author":"Zheng","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"B444","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3343\/alm.2021.41.1.25","article-title":"Application of next generation sequencing in laboratory medicine","volume":"41","author":"Zhong","year":"2021","journal-title":"Ann. Lab. Med."},{"key":"B445","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/diagnostics14101045","article-title":"A Comprehensive review on circulating cfRNA in plasma: implications for disease diagnosis and beyond","volume":"14","author":"Zhong","year":"2024","journal-title":"Diagn. (Basel)"},{"key":"B446","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.1038\/srep11516","article-title":"Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"key":"B447","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mco2.41","article-title":"Neoantigen-reactive T cell: an emerging role in adoptive cellular immunotherapy","volume":"2","author":"Zhu","year":"2021","journal-title":"MedComm (Beijing)"},{"key":"B448","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1038\/s41467-025-61034-3","article-title":"Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"B449","doi-asserted-by":"publisher","first-page":"bbaf541","DOI":"10.1093\/bib\/bbaf541","article-title":"Deep learning approaches for resolving genomic discrepancies in cancer: a systematic review and clinical perspective","volume":"26","author":"Zubair","year":"2025","journal-title":"Brief. Bioinform"},{"key":"B450","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jcyt.2022.03.011","article-title":"Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies","volume":"24","author":"Zurko","year":"2022","journal-title":"Cytotherapy"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1828450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:42:07Z","timestamp":1783298527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1828450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":450,"alternative-id":["10.3389\/fgene.2026.1828450"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1828450","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1828450"}}